Recombinant Mouse MOG Protein, CF Summary
Product Specifications
Gly29-Gly153, with a C-terminal 10-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
8536-MO
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: MOG
Myelin oligodendrocyte glycoprotein (MOG) is 28 kDa single-pass transmembrane glycoprotein that is a member of the Ig superfamily (1-4). Mouse MOG is synthesized with a 28 amino acid (aa) signal sequence, a 128 aa extracellular domain (ECD) containing an Ig-like domain, a 21 aa transmembrane domain, and a 69 aa cytosolic fragment featuring a hydrophobic domain that associates with the cytoplasmic face of the plasma membrane. The ECD of mature mouse MOG shares 90% and 95% aa sequence identity with the ECD of human and rat MOG, respectively. Dimerization of MOG occurs via the extracellular Ig-like domain (5-8). MOG is expressed exclusively by oligodendrocytes in the central nervous system (CNS) and is localized to the outer layer of the myelin sheath as well as in the oligodendrocyte plasma membrane (9). MOG expression in the brain can be used as a temporal biomarker for myelin development. MOG is an important antigenic target for autoimmune diseases that mediate demyelination in the CNS (10). In vivo administration of exogenous MOG protein or peptide induces experimental autoimmune encephalomyelitis (EAE) in multiple animal species (11, 12). EAE is used as an animal model for multiple sclerosis and related CNS demyelinating diseases. MOG is thought function as an adhesion molecule as well as a mediator of immune activation in the CNS (2, 9, 13).
- Johns, T.G. and C.C. Bernard (1999) J. Neurochem. 72:1.
- Pham-Dinh, D. et al. (1993) Proc. Natl. Acad. Sci. U S A 90:7990.
- Hilton, A.A. et al. (1995) J. Neurochem. 65:309.
- Slavin, A.J. et al. (1997) Dev. Neurosci. 19:69.
- Abo, S. et al. (1993) Biochem. Mol. Biol. Int. 30:945.
- Amiguet, P. et al. (1992) J. Neurochem. 58:1676.
- Bettadapura, J. et al. (1998) J. Neurochem. 70:1593.
- Clements, C.S. et al. (2003) Proc. Natl. Acad. Sci. U S A 100:11059.
- Reindl, M. et al. (2013) Nat. Rev. Neurol. 9:455.
- von Budingen, H.C. et al. (2004) Eur. J. Immunol. 34:2072.
- Rangachari, M. and V.K. Kuchroo (2013) J. Autoimmun. 45:31.
- Tompkins, S.M. et al. (2002) J. Immunol. 168:4173.
- Garcia-Vallejo, J.J. et al. (2014) J. Exp. Med. 211:1465.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Mouse MOG Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Mouse MOG Protein, CF and earn rewards!
Have you used Recombinant Mouse MOG Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image